Astellas Pharma Inc 2022 Integrated Report
Company: Astellas Pharma Inc
Sector: Manufacturing
Country: Japan
Year: 2022
Type: Integrated Report
Pages: 92
The report describes the company's FY2021 refresh of its Materiality Matrix, including 19 key issues and 9 prioritized material issues, alongside a new Access to Medicine strategy and four health system strengthening programs. It also reports qualitative scenario analysis aligned to TCFD recommendations. Environmental highlights include 1,933 tons of GHG reductions from climate mitigation measures and 29% renewable energy within total energy consumption.
Services
From bulk PDFs to structured indicators and machine-readable documents.